The research article from Georgia Tech addresses an important issue in the current battle against cancer – the development of resistance to anticancer drugs, which leads to the loss of efficacy of chemotherapeutic treatment.
Unusual compound is the first metallic oxygen ion conductor of its kind, as well as the first that is active at room temperature.
ETH researchers have developed plasmonic particles that are relatively easy to produce and have a wide range of applications, including cancer treatment.
A study to investigate how nanoparticles could be used to improve the diagnosis and treatment of cardiovascular disease has received £3 million funding.
New method allows researchers to directly measure nanoparticle degradation in real time within biological environments.
Korean scientists have developed a tumor-targeted, bioreducible nanoparticle system that can deliver cytotoxic anticancer drugs to tumor tissues.
Recent research into the use of polymer-coated nanoparticles for enhanced oil recovery is reviewed in the Journal of Applied Polymer Science.
New core/shell structure nanoparticles have been reported by a team led by Peking University researchers.
Drugs used to treat blindness-causing disorders could be successfully administered by eye drops rather than unpleasant and expensive eye injections.
G. Han and co-workers have reported real-time recording of tuned upconversion nanoparticles mediating rapid photoactivation down to just a few cells.